首页> 外文期刊>Archives of Physical Medicine and Rehabilitation >Serial ultrasonographic findings of plantar fasciitis after treatment with botulinum toxin a: a case study.
【24h】

Serial ultrasonographic findings of plantar fasciitis after treatment with botulinum toxin a: a case study.

机译:肉毒杆菌毒素a治疗后足底筋膜炎的系列超声检查结果:一项病例研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Plantar fasciitis is a common cause of heel pain and is the result of a degenerative process of the plantar fascia at its calcaneal attachment. A case study of a preliminary experience with local injections of botulinum toxin A (BTX-A) for the treatment of chronic plantar fasciitis in a 43-year-old woman is presented. We injected the patient with 70 units of BTX-A (0.7mL) in 2 divided doses: 40 units (0.4mL) in the tender region of the heel, and 30 units (0.3mL) in the most tender point of the foot arch. Visual analog scale (VAS) and pressure pain threshold (PPT) were measured to evaluate the efficacy of BTX-A injections. Real-time, high-resolution ultrasonographic findings of the plantar fascia after BTX-A injections were also used for serial follow-ups. After BTX-A injection, decreased VAS values were reported and increased PPT was observed. In ultrasonographic studies, the thickness of the plantar fascia and the hypoechogenicity of the fascia were reduced. Decreased plantar fascia thickness was observed on the first and third week after BTX-A injections. The findings were compatible with the changes in pain assessed by VAS and PPT. Ultrasonographic findings also indicated a progressive decrease in the thickness of the underlying muscle belly. Ultrasonography seems to be a valuable, noninvasive diagnostic tool for the evaluation of plantar fasciitis treated with BTX-A injections. It can offer objective measurements of therapeutic effects and is feasible for serial follow-ups.
机译:足底筋膜炎是足跟痛的常见原因,是足底筋膜跟骨附着处退化过程的结果。本文介绍了一个局部注射肉毒毒素A(BTX-A)来治疗43岁女性慢性足底筋膜炎的初步经验的案例研究。我们为患者注射了70单位的BTX-A(0.7mL),分为2个剂量:足跟的嫩部40单位(0.4mL),足弓最嫩部30单位(0.3mL) 。测量视觉模拟量表(VAS)和压力痛阈值(PPT)以评估BTX-A注射的疗效。 BTX-A注射后足底筋膜的实时,高分辨率超声检查结果也用于连续随访。 BTX-A注射后,报告的VAS值降低,并且观察到PPT升高。在超声检查中,足底筋膜的厚度和筋膜的抗回声性降低。 BTX-A注射后第一周和第三周观察到足底筋膜厚度减小。这些发现与通过VAS和PPT评估的疼痛变化相符。超声检查结果还表明潜在的腹部肌肉厚度逐渐减少。超声检查似乎是评估用BTX-A注射治疗的足底筋膜炎的有价值的非侵入性诊断工具。它可以提供客观的治疗效果测量,并且对于后续随访是可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号